Table 1 Patient characteristics

Age (years)

53 (36.5– 59)

40 (33–43)

45 (35–49)

Gender (females)

5

4

3

 CRP (mg/L)

19 (8.7–20.75)

16.25 (5.5–44.13)

4 (3–5)

 DAS28CRP

3.71 (3.19–4.12)

3.50 (2.90–4.66)

3.01 (2.79–3.68)

 Swollen joint count

1 (1–2.75)

1.5 (1–2)

1.5 (0.75–5.25)

 Tender joint count

1 (1–2.5)

1 (1–2)

1.5 (0.75–3)

 Disease duration (years)

11 (5–18)

2 (0.5–15)

14 (5–14)

 RF positive (n)

4

0

0

 Anti-CCP positive (n)

4

0

0

 HLA-B27 (n)

–

5

–

  MTX (n)

10

2

3

  Salazopyrine (n)

3

3

0

  TNF-inhibitor (n)

4

4

1

No DMARDs (n)

2

4

2